Merck to cut 1,200 sales jobs

Share this article:
Merck announced plans to cut 1,200 sales jobs in the US. The layoffs follow an FDA rejection of Cordaptive, a cholesterol drug that was to be packaged with Zocor, and weak sales of Vytorin following the ENHANCE controversy.
Share this article:

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.